↓ SCROLL TO SEE MORE ↑

What are you looking for?

News

Turkish COVID-19 vaccine ready to apply for emergency use approval

Turkish COVID-19 vaccine ready to apply for emergency use approval

The development process of the Turkish vaccine Turkovac against COVID-19 has reached a stage where it can apply for an emergency use approval, Health Minister Fahrettin Koca said.

Koca pointed out that earlier the production of the vaccine had been established at one of the country’s enterprises.

The infrastructure has been created in Turkey, which makes it possible to launch the second enterprise for the mass production of Turkovac, he added.

“If approved, we will start mass production in October,” said Koca.

The Turkovac vaccine was developed by scientists from Erciyes University in collaboration with the Turkish Institutes of Health Administration (TÜSEB) under the Turkish Ministry of Health.

The first vaccines in the third phase of clinical trials were administered to volunteers on June 22 at Ankara City Hospital.

The development of a domestic vaccine against coronavirus began from the first days of the pandemic with the coordination and support of TÜSEB and the country’s Ministry of Health.

Turkovac became the first domestic inactive vaccine against a new type of coronavirus.

At all stages – from scientific infrastructure to technology and research – the development was carried out using exclusively domestic potential. The vaccine is the result of the overwhelming and collaborative work of many stakeholders and scientists.